See the Glossary for more terms.
If you find writing applications "therapeutic," you may be interested in a pair of NIAID RFAs.
Both are for phased innovation awards (R21/R33), which pack a one-two punch. That is, they require one application to cover two phases and result in little or no funding gap between phases. To learn more, see our R21/R33 Phased Innovation Award SOP.
Now, without further ado, a brief description of the RFAs.
Therapeutics for Neurotropic Biodefense Toxins and Pathogens
With this initiative, NIAID is looking for projects focused on developing novel therapeutic strategies that address intoxication or infection of the brain or neurons by select biodefense toxins and pathogens.
Get the full scoop in the May 27, 2011, Guide notice. Applications are due October 24, 2011. If you want to submit a letter of intent, do so by September 23, 2011.
Host-Targeted Interventions as Therapeutics for Infectious Diseases
This RFA seeks innovative research on therapeutics that target host-encoded functions needed for infection, replication, spread, or pathogenesis by one or more NIAID Category A, B, and C Priority Pathogens.
Read the July 19, 2011, Guide notice for all the details. The application deadline is November 30, 2011, with optional letters of intent due by October 31, 2011.
Want to jump-start getting your technology to market? If you are a Small Business Innovation Research (SBIR) phase I awardee, sign up for NIH's annual Niche Assessment Program. It’s free and takes only a few hours of your time.
An NIH contractor will assess your technology and all its possible uses, then draft a market analysis report to help you figure out the best way to position your technology in the marketplace. You can use the report as you prepare the commercialization plan required for your phase II application.
The program can also introduce you to potential business partners.
Only 100 slots are open for NIH FY 2011 and FY 2012 awardees on a first come, first served basis. If you have multiple awards, you can pick only one project for the assessment. The analysis takes on average two to three months to complete.
For more details and registration forms, see the July 15, 2011, Guide notice.
Every year, we nudge you about the September deadline for NRSA Institutional Research Training Grants (T32) and Short-Term Institutional Research Training Grants (T35). This reminder is a little different.
We're still giving you a heads up but emphasizing that unlike previous years the September 25 submission date is for only non-AIDS applications. AIDS-related applications are due January 7.
Be aware that NIH just revised instructions for the appendix materials of T32 and T35 applications. Get details in the July 28, 2011, Guide notice. We'll tell you more about that in our next issue.
If you need help writing your application or want general information on your grant type, our Web site can help. This goes for anyone applying for fellowships (F) and career development awards (K) as well.
Start with the Training and Career portal. On that page, you'll find links to resources like:
To fix some technical problems with grant application forms, NIH reissued the following parent announcements with new grant application packages:
Application instructions are the same.
Confirm that you have the right forms before you apply—check that the package is marked "ADOBE-FORMS-B2" and read the July 13, 2011, Guide notice for more information.
You've contacted your grants management specialist but haven't had any luck in getting a response. What should you do, especially when time is of the essence?
Know whom to contact. If you're wondering about your chances of getting funded, contact your program officer. If you already have a grant or if a grants management specialist contacted you about an award, get in touch with grants management.
To contact your grants management specialist, start with an email. Be sure to copy your program officer and provide your grant or application number.
Grants management specialists should typically respond to you by the end of the next business day. However, from July to September it may take two business days to get back to you.
If you get no reply within the typical timeframe, follow up with a call to the grants management specialist.
If you still don't hear back from your grants management specialist, contact the most appropriate branch chief. To see who that is, go to Grants Management Program Contacts.
If the branch chief doesn't reply in two business days, contact the head of the Grants Management Program, Mary Kirker, and copy the director of DEA, Matthew Fenton.
For questions that don't require your grants management specialist's attention, you have other ways to get answers.
Here's a tip tailored for the fast-approaching end of fiscal year: if you can afford to wait, please do. Specialists' workloads get heavier around this time, but perhaps more so this year. We explain why in our July 20, 2011, article "Still Have Paperwork for NIAID? Do It Now."
We wrote a related article on getting in touch with your program officer. See our May 25, 2011, article "Waiting for Your Program Officer to Respond? Here's What to Do."
Keep your fingers clean and your institution safe: always disclose potential conflicts of financial interest to your business office.
As a condition for receiving an NIH grant, your institution has to manage, reduce, or eliminate all conflicts for you, your subawardees, and collaborators. If it doesn’t, we won't fund your research.
Know the rules and check with your institutional official to see what you need to do.
For more information, read our Financial Conflicts of Interest for Awardees SOP and visit NIH's Financial Conflict of Interest page. The only people exempt from this regulation are small business awardees, investigators with training grants, and recipients of fellowship awards.
Feel free to send us a question at email@example.com. After responding to you, we may include your question in the newsletter, incorporate it into the NIAID Research Funding site, or both.
"In my progress report, do I need to spell out my Specific Aims?"—Charles Paxton, University of Washington
Only if you have modified them. Follow the Non-Competing Continuation Progress Report PHS 2590 instructions.
Still, we suggest that you state your aims even if they haven't changed because program officers find it very helpful. Doing so makes it easier to immediately recall the goals of the grant and put the progress in context.
"I have a subaward from an NIAID grantee. Do I need NIAID's permission to keep my subaward if I go to another institution?"—Holly Elphinstone, London Research Institute
No. We deal with the grantee institution directly, and so should you. That institution may need to request our prior approval to continue the subaward once you transfer, so be prepared to provide documentation or support to its business office but do not send anything to NIAID.
To see all instances where grantees need NIAID's prior approval, read the Prior Approvals for Post-Award Grant Actions SOP.
See these and older announcements at NIAID Funding Opportunities List.
back to top
Last Updated March 19, 2012
Last Reviewed August 03, 2011